Advertisement
U.S. markets close in 40 minutes

Laboratory Corporation of America Holdings (LH)

NYSE - Nasdaq Real Time Price. Currency in USD
218.27+1.70 (+0.78%)
As of 03:17PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close216.57
Open216.74
Bid217.98 x 800
Ask218.05 x 800
Day's Range215.64 - 218.39
52 Week Range179.59 - 234.09
Volume265,863
Avg. Volume743,178
Market Cap18.357B
Beta (5Y Monthly)1.00
PE Ratio (TTM)50.41
EPS (TTM)4.33
Earnings DateApr 25, 2024
Forward Dividend & Yield2.88 (1.33%)
Ex-Dividend DateFeb 26, 2024
1y Target Est246.80
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
35% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for LH

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Laboratory Corporation of Ameri
    Analyst Report: Laboratory Corp. Of America HlLabCorp operates one of the largest global clinical laboratory networks, managing more than 160 million patient encounters each year, or more than 3 million patient specimens per week. LabCorp businesses also support clinical trial activity in approximately 100 countries. LabCorp has a market cap of about $18 billion. The company is a component of the S&P 500.
    Rating
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more
  • PR Newswire

    Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health.

  • PR Newswire

    Labcorp to Announce First Quarter Financial Results on April 25, 2024

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the first quarter of 2024 before the market opens on Thursday, April 25, 2024. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.

  • Zacks

    Labcorp (LH) Boost Diagnostics Suite With New Biomarker Test

    Labcorp's (LH) pTau217 test is a pivotal blood biomarker intended to aid in the diagnosis of Alzheimer's disease.